Archive

Medical Category: Thoracic and Respiratory

REBEL Core Cast – Basics of EM – Sore Throat

Take Home Points Look for the red flags – fever, drooling, neck stiffness, toxic ingestion, uvula deviation, voice changes Steroids help with swelling Obtain CT soft tissue neck for concerning presentations Don’t be a cowboy/cowgirl – get consultants involved early …

Read More
Head, Eye, Ear, Nose, and ThroatInfectious DiseaseThoracic and Respiratory

REBEL Core Cast – Basics of EM – Introduction

REBEL Core Cast – Basics of Emergency Medicine Podcast Welcome to the EMRA Basics of Emergency Medicine Podcast. I am your host EJ Wright, and the following series is an all encompassing approach to the most common chief complaints in …

Read More
Abdominal and GastroinstestinalAllergy and ImmunologyCardiovascularDermatologyEndocrine, Metabolic, Fluid, and ElectrolytesEnvironmentalHead, Eye, Ear, Nose, and ThroatHematology and OncologyInfectious DiseaseNeurologyObstetrics and GynecologyOrthopedicsRenal and GenitourinaryResuscitationThoracic and RespiratoryToxicologyTrauma

The INSPIRATION Trial: Intermediate Dose Anticoagulation in Critically Ill Patients with COVID-19

Background: COVID-19 infection increases the risk of thrombosis due to multiple factors.(Rico-Mesa, 2020). Over the last 2 years, researchers have published 12 RCTs investigating various anticoagulation strategies among patients diagnosed with COVID-19 in multiple clinical settings. To date, only a multiplatform …

Read More
CardiovascularHematology and OncologyInfectious DiseaseThoracic and Respiratory

The COV-BOOST Trial: Safety and Immunogenicity of Boosters

Background: COVID-19 became an international pandemic in March of 2020, claiming the lives of millions of people worldwide. To combat this deadly virus, an unprecedented global effort led to the development of many new vaccines against COVID-19 within a year. …

Read More
Infectious DiseaseThoracic and Respiratory

The SCOUT–CAP Trial: 5d Abx vs. 10d Abx in Pediatric CAP

Background: The standard approach to treating pediatric community-acquired pneumonia (CAP) is a 10-day course of antibiotics. However, two high-quality randomized control trials challenged this standard within the last 12 months. The SAFER Trial [reviewed here] and CAP-IT Trial [reviewed here] found treatment for CAP in …

Read More
Infectious DiseasePediatricsThoracic and Respiratory

Sponsored